First- vs Second-Generation Antipsychotic Drugs in Schizophrenia—Reply
暂无分享,去创建一个
Peter B. Jones | R. Murray | G. Dunn | T. Barnes | L. Davies | S. Lewis | K. Hayhurst | H. Lloyd | Pete Elton | Alison Marwick
[1] R. Rosenheck. Outcomes, costs, and policy caution. A commentary on: the Cost Utility of the Latest Antipsychotic Drugs in Schizophrenia Study (CUtLASS 1). , 2006, Archives of general psychiatry.
[2] J. Lieberman. Comparative effectiveness of antipsychotic drugs. A commentary on: Cost Utility Of The Latest Antipsychotic Drugs In Schizophrenia Study (CUtLASS 1) and Clinical Antipsychotic Trials Of Intervention Effectiveness (CATIE). , 2006, Archives of general psychiatry.
[3] Peter B. Jones,et al. Randomized controlled trial of the effect on Quality of Life of second- vs first-generation antipsychotic drugs in schizophrenia: Cost Utility of the Latest Antipsychotic Drugs in Schizophrenia Study (CUtLASS 1). , 2006, Archives of general psychiatry.